HOME  |  CONTACT  |  SITEMAP   
Home > 교실소개 > 임상의학 > 교수진 명단

| 교수진 명단



    • 홍석찬 부교수

    내과학

    패스워드가 일치하지 않습니다.

    전공분야

    면역, 류마티스질환

    소속연구단

    관련/관심분야

        데이터가 없습니다.

    주요논문

    1. Febuxostat dose requirement according to renal function in patients who achieve target serum urate levels: A retrospective cohort study [ JOINT BONE SPINE ] - 2024.03.01
    2. Clinical features of systemic lupus erythematosus patients with splenomegaly: focussed on the cytopenias [ INTERNAL MEDICINE JOURNAL ] - 2023.12.01
    3. Recovery and long-term renal outcome of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis who are on dialysis at presentation [ International Journal of Rheumatic Diseases ] - 2023.10.01
    4. Long-term renal outcomes of patients with non-proliferative lupus nephritis [ The Korean Journal of Internal Medicine ] - 2023.09.01
    5. Prognostic value of proteinuria monitoring in anti-neutrophil cytoplasmic antibody-associated vasculitis [ Clinical and Experimental Nephrology ] - 2023.08.01
    6. Clinical significance of tocilizumab-related neutropenia in patients with rheumatoid arthritis [ JOINT BONE SPINE ] - 2023.05.01
    7. Risk of bleeding-related complications after kidney biopsy in patients with systemic lupus erythematosus [ CLINICAL RHEUMATOLOGY ] - 2023.03.01
    8. Circulating and renal fibrocytes are associated with interstitial fibrosis in lupus nephritis [ RHEUMATOLOGY ] - 2023.02.01
    9. Angiographic patterns and temporal changes of arterial lesions in Behcet's disease [ Vascular ] - 2022.12.01
    10. Disease Flare of Systemic Lupus Erythematosus in Patients With Endstage Renal Disease on Dialysis [ JOURNAL OF RHEUMATOLOGY ] - 2022.10.01
    11. Prognostic factors for the development of systemic lupus erythematosus in patients with immune thrombocytopenia [ ARTHRITIS RESEARCH & THERAPY ] - 2022.09.06
    12. Risk of Hepatitis B Virus (HBV) Reactivation in Patients with Immune-Mediated Inflammatory Diseases Receiving Biologics: Focus on the Timing of Biologics after Anti-HBV Treatment [ Gut and Liver ] - 2022.07.15
    13. Safety of JAK inhibitor use in patients with rheumatoid arthritis who developed herpes zoster after receiving JAK inhibitors [ CLINICAL RHEUMATOLOGY ] - 2022.06.01
    14. Renal outcomes of transient proteinuria in patients with systemic lupus erythematosus treated with corticosteroid therapy alone [ LUPUS ] - 2022.05.01
    15. Neutrophil extracellular trap clearance by synovial macrophages in gout [ ARTHRITIS RESEARCH THERAPY ] - 2021.03.01
    16. The Emerging Role of Renal Tubular Epithelial Cells in the Immunological Pathophysiology of Lupus Nephritis [ FRONTIERS IN IMMUNOLOGY ] - 2020.09.23
    17. Immunological characteristics and possible pathogenic role of urinary CD11c+ macrophages in lupus nephritis [ RHEUMATOLOGY ] - 2020.08.01
    18. Rapid reduction in uric acid by a urate-lowering agent is associated with recurrent cardiovascular events [ MEDICAL HYPOTHESES ] - 2020.08.01
    19. Clinical and histological significance of urinary CD11c + macrophages in lupus nephritis [ ARTHRITIS RESEARCH & THERAPY ] - 2020.07.01
    20. Synovial fluid CD69+CD8+ T cells with tissue?resident phenotype mediate perforin?dependent citrullination in rheumatoid arthritis [ Clinical & Translational Immunology ] - 2020.06.08
    21. Methotrexate-related toxicity in patients with rheumatoid arthritis and renal dysfunction [ RHEUMATOLOGY INTERNATIONAL ] - 2020.05.01
    22. Effect of TNF inhibitors on bone mineral density in rheumatoid arthritis patients receiving bisphosphonate: a retrospective cohort study [ RHEUMATOLOGY INTERNATIONAL ] - 2020.03.01
    23. Recovery of Renal Function in Patients With Lupus Nephritis and Reduced Renal Function: The Beneficial Effect of Hydroxychloroquine [ LUPUS ] - 2020.01.01
    24. Clinical features and recurrent attack in gout patients according to serum urate levels during an acute attack [ Korean Journal of Internal Medicine ] - 2020.01.01
    25. Impact of stringent response in proteinuria on long-term renal outcomes in proliferative lupus nephritis [ LUPUS ] - 2019.10.01
    26. Prominent Inflammatory Features of Monocytes/Macrophages in Acute Calcium Pyrophosphate Crystal Arthritis: a Comparison with Acute Gouty Arthritis [ IMMUNE NETWORK ] - 2019.06.01
    27. Hepatic Safety of Febuxostat Compared with Allopurinol in Gout Patients with Fatty Liver Disease [ JOURNAL OF RHEUMATOLOGY ] - 2019.05.01
    28. Clinical features and risk of recurrence of acute calcium pyrophosphate crystal arthritis [ CLINICAL AND EXPERIMENTAL RHEUMATOLOGY ] - 2019.03.01
    29. Non-albumin proteinuria as a parameter of tubulointerstitial inflammation in lupus nephritis [ CLINICAL RHEUMATOLOGY ] - 2019.01.01
    30. Safety of the concomitant use of methotrexate and a prophylactic dose of trimethoprim-sulfamethoxazole [ CLINICAL RHEUMATOLOGY ] - 2018.12.01
    31. Predicting eventual development of lupus nephritis at the time of diagnosis of systemic lupus erythematosus [ SEMINARS IN ARTHRITIS AND RHEUMATISM ] - 2018.12.01
    32. CD14(+) Cells with the Phenotype of Infiltrated Monocytes Consist of Distinct Populations Characterized by Anti-inflammatory as well as Pro-inflammatory Activity in Gouty Arthritis [ FRONTIERS IN IMMUNOLOGY ] - 2017.10.06
    33. Risk of Colchicine-Associated Myopathy in Gout: Influence of Concomitant Use of Statin [ AMERICAN JOURNAL OF MEDICINE ] - 2017.05.01
    34. Longterm Outcomes of Renal Artery Involvement in Takayasu Arteritis [ JOURNAL OF RHEUMATOLOGY ] - 2017.04.01
    35. Basophil-derived IL-6 regulates TH17 cell differentiation and CD4 T cell immunity [ SCIENTIFIC REPORTS ] - 2017.01.30
    36. Clinical outcomes of hydronephrosis in patients with systemic lupus erythematosus [ International Journal of Rheumatic Diseases ] - 2016.12.01
    37. Late-onset IgA vasculitis in adult patients exhibits distinct clinical characteristics and outcomes [ CLINICAL AND EXPERIMENTAL RHEUMATOLOGY ] - 2016.05.15
    38. The Incidence of Uveitis in Ankylosing Spondylitis Patients Undergoing Tumor Necrosis Factor Inhibiting Therapy in Korea [ 대한류마티스학회지 ] - 2015.10.01
    39. Outcome of Takayasu Arteritis with Inactive Disease at Diagnosis: The Extent of Vascular Involvement As a Predictor of Activation [ JOURNAL OF RHEUMATOLOGY ] - 2015.03.01
    40. TNF-α confers resistance to Fas-mediated apoptosis in rheumatoid arthritis through the induction of soluble Fas [ LIFE SCIENCES ] - 2015.02.01
    41. 류마티스 다발근통의 진단과 치료 [ 대한내과학회지 ] - 2014.05.01

    연구과제 수주실적

    1. 류마티스 관절염에서 조직 상주 T세포 역할 규명 및 제어기술 개발 - 2022.01.01 ~ 2022.12.31
    2. 류마티스 관절염에서 조직 상주 T세포 역할 규명 및 제어기술 개발 - 2021.01.01 ~ 2021.12.31
    3. 루푸스 신염에서의 섬유세포의 역할 규명을 통한 신조직 섬유화 예측 신규 바이오마커 발굴 - 2021.01.01 ~ 2021.12.31
    4. 루푸스 신염에서 장기생존 형질세포의 역할 규명을 통한 새로운 치료 타겟 발굴 - 2020.02.01 ~ 2020.07.31
    5. 류마티스 관절염에서 조직 상주 T세포 역할 규명 및 제어기술 개발 - 2020.01.01 ~ 2020.12.31
    6. 류마티스 관절염에서 조직 상주 T세포 역할 규명 및 제어기술 개발 - 2019.04.01 ~ 2019.12.31
    7. 루푸스 신염에서 장기생존 형질세포의 역할 규명을 통한 새로운 치료 타겟 발굴 - 2019.04.01 ~ 2020.01.31
    8. 류마티스 관절염에서 조직 상주 T세포 역할 규명 및 제어기술 개발 - 2018.10.01 ~ 2019.03.31
    9. 루푸스 신염에서 장기생존 형질세포의 역할 규명을 통한 새로운 치료 타겟 발굴 - 2018.06.01 ~ 2019.03.31
    10. 루푸스 신염에서 소변 세포 분석을 통한 새로운 바이오 마커 발굴 - 2018.01.01 ~ 2018.12.27
    11. 요산에 의한 염증 및 혈전생성 연구를 통한 심혈관 질환의 새로운 기전 및 치료법 제시 - 2017.12.01 ~ 2018.11.30
    12. 루푸스 신염에서 장기생존 형질세포의 역할 규명을 통한 새로운 치료 타겟 발굴 - 2017.08.01 ~ 2018.05.31
    13. 루푸스 신염에서 장기생존 형질세포의 역할 규명을 통한 새로운 치료 타겟 제시 - 2017.01.01 ~ 2017.12.31
    14. 요산에 의한 염증 및 혈전생성 연구를 통한 심혈관 질환의 새로운 기전 및 치료법 제시 - 2016.12.01 ~ 2017.11.30
    15. 루푸스 신염에서 장기생존 형질세포의 역할 규명을 통한 새로운 치료 타겟 발굴 - 2016.11.01 ~ 2017.07.31
    16. 통풍 관절염에서 미세입자 및 inflammasome 활성화가 심혈관 질환 위험도 증가에 가지는 역할 규명 - 2016.01.01 ~ 2016.12.31
    17. 요산에 의한 염증 및 혈전생성 연구를 통한 심혈관 질환의 새로운 기전 및 치료법 제시 - 2015.12.03 ~ 2016.11.30
    18. 통풍 관절염에서 미세입자 및 inflammasome 활성화가 심혈관 질환 위험도 증가에 가지는 역할 규명 - 2015.01.01 ~ 2015.12.31

    특허/기술이전실적

      데이터가 없습니다.

    국내외 경력

          데이터가 없습니다.

     공지

    이전으로